| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |